Recently, the EG-017 Phase II clinical trial program seminar and kick-off meeting jointly conducted by Beijing New Leading Zhengzhou Deep Blue Sea and Ningbo Xijian Pharmaceutical Technology Co., Ltd. was successfully held in the form of offline main venue (Beijing)+online video conference.

Recently, the Phase III clinical trial scheme discussion of recombinant human erythropoietin -Fc fusion protein for injection (hereinafter referred to as "rhEPO-Fc fusion protein") jointly conducted by Beijing New Leading Zhengzhou Deep Blue Sea and Shandong Danhong Pharmaceutical (a wholly-owned subsidiary of Buchang Pharmaceutical) was successfully held in the form of offline main venue (Beijing)+online video conference.

On September 27th, the "Sub-Forum 5 of the Second Zhengzhou International Biomedical Development Summit Forum-CXO Innovation Service Forum of Pharmaceutical R&D and Transformation Industry Chain", jointly sponsored by the Pharmaceutical Chamber of Commerce of All-China Federation of Industry and Commerce, R&D and Transformation Service Professional Committee of China Food and Drug Enterprise Quality and Safety Promotion Association, and Shenzhen Shenlanhai, a new leader in Beijing, was a complete success! Experts, scholars and enterprise representatives gathered together to discuss the development direction of CXO's innovative service in the whole industrial chain, and help the innovation and development of China's biomedical industry.

On September 26th, the "Second Zhengzhou International Biomedical Development Summit Forum", co-sponsored by Beijing New Leader, was grandly opened in Zhengzhou Airport Biomedical Park. He Wei, Vice Chairman of the National Committee of the Chinese People's Political Consultative Conference and Executive Vice Chairman of the Central Committee of the Agricultural Workers' Party, delivered a video report. More than 500 experts and scholars from scientific research institutions, enterprises and government supervision departments at home and abroad, including Chen Kaixian, academician of Chinese Academy of Sciences, and Zhang Gaiping, academician of Chinese Academy of Engineering, were invited to attend the meeting. anagement Committee, attended the opening ceremony and delivered a speech.

Recently, Beijing New Leading and the School of Chemistry and Chemical Engineering of Beijing Institute of Technology formally signed a strategic cooperation agreement. The two sides will establish a shared cooperation platform, accelerate the integration of production, education and research, and promote the transformation of scientific research achievements by complementing each other's advantages to achieve complementary advantages, win-win cooperation and common development.